<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Torres-Odio S</submitter><funding>NHLBI NIH HHS</funding><funding>Office of the Assistant Secretary of Defense for Health Affairs, U.S. Department of Defense</funding><funding>National Heart, Lung, and Blood Institute, National Institutes of Health</funding><pagination>1890-1900</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8026707</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>206(8)</volume><pubmed_abstract>Caseinolytic mitochondrial matrix peptidase proteolytic subunit (CLPP) is a serine protease that degrades damaged or misfolded mitochondrial proteins. CLPP-null mice exhibit growth retardation, deafness, and sterility, resembling human Perrault syndrome, but also display immune system alterations. However, the molecular mechanisms and signaling pathways underlying immunological changes in CLPP-null mice remain unclear. In this study, we report the steady-state activation of type I IFN signaling and antiviral gene expression in CLPP-deficient cells and tissues, resulting in marked resistance to RNA and DNA virus infection. Depletion of the cyclic GMP-AMP (cGAS)-stimulator of IFN genes (STING) DNA sensing pathway reduces steady-state IFN-I signaling and abrogates the broad antiviral phenotyp</pubmed_abstract><journal>Journal of immunology (Baltimore, Md. : 1950)</journal><pubmed_title>Loss of Mitochondrial Protease CLPP Activates Type I IFN Responses through the Mitochondrial DNA-cGAS-STING Signaling Axis.</pubmed_title><pmcid>PMC8026707</pmcid><funding_grant_id>R01HL148153</funding_grant_id><funding_grant_id>W81XWH-20-1-0150</funding_grant_id><funding_grant_id>W81XWH-17-1-0052</funding_grant_id><funding_grant_id>R01 HL148153</funding_grant_id><pubmed_authors>West AP</pubmed_authors><pubmed_authors>Torres-Odio S</pubmed_authors><pubmed_authors>Wittig I</pubmed_authors><pubmed_authors>Menissy SS</pubmed_authors><pubmed_authors>Lei Y</pubmed_authors><pubmed_authors>Key J</pubmed_authors><pubmed_authors>Auburger G</pubmed_authors><pubmed_authors>Gispert S</pubmed_authors><pubmed_authors>Maletzko A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of Mitochondrial Protease CLPP Activates Type I IFN Responses through the Mitochondrial DNA-cGAS-STING Signaling Axis.</name><description>Caseinolytic mitochondrial matrix peptidase proteolytic subunit (CLPP) is a serine protease that degrades damaged or misfolded mitochondrial proteins. CLPP-null mice exhibit growth retardation, deafness, and sterility, resembling human Perrault syndrome, but also display immune system alterations. However, the molecular mechanisms and signaling pathways underlying immunological changes in CLPP-null mice remain unclear. In this study, we report the steady-state activation of type I IFN signaling and antiviral gene expression in CLPP-deficient cells and tissues, resulting in marked resistance to RNA and DNA virus infection. Depletion of the cyclic GMP-AMP (cGAS)-stimulator of IFN genes (STING) DNA sensing pathway reduces steady-state IFN-I signaling and abrogates the broad antiviral phenotyp</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2026-05-09T20:09:57.839Z</modification><creation>2025-02-19T00:56:26.682Z</creation></dates><accession>S-EPMC8026707</accession><cross_references><pubmed>33731338</pubmed><doi>10.4049/jimmunol.2001016</doi></cross_references></HashMap>